SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-298718
Filing Date
2023-12-19
Accepted
2023-12-19 17:20:01
Documents
13
Period of Report
2023-12-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d719875d8k.htm   iXBRL 8-K 23868
2 EX-99.1 d719875dex991.htm EX-99.1 6526
  Complete submission text file 0001193125-23-298718.txt   151063

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gh-20231219.xsd EX-101.SCH 2854
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20231219_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20231219_pre.xml EX-101.PRE 10817
7 EXTRACTED XBRL INSTANCE DOCUMENT d719875d8k_htm.xml XML 3223
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 231498508
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)